CAVE CREEK, AZ--(NewMediaWire - Apr 19, 2017) - Endexx
Corporation (OTC PINK: EDXC),
a provider of innovative phytonutrient-based food and nutritional
products, announced that its Cannabidiol (CBD)-infused gourmet tea
beverages are now available for purchase and is shipping to
pre-order customers. The first batch of tea consists of 150 lbs.,
and produced over 28,000 tea bags.
Endexx's first product launch Third Eye Chai™, a masala chai
tea, was a result of its license and distribution deal with The Mad
Hatter Coffee & Tea Co. The collaboration offers a major
opportunity to bring specific hemp and CBD-infused natural blends
to the global health and whole foods markets, a major step for the
cross-over markets valued at over $3 billion.
Todd Davis, CEO of Endexx, stated, "Our CBD-infused Chai, is
primarily a wellness product that contains only the finest tea and
herb ingredients and provides our customers with an enhanced tea
experience. Although there is still a lot of education to be done
on the health benefits of CBD, it has been proven to alleviate
inflammation, muscle spasms, anxiety, epileptic seizures, and pain.
Our licensing and partnership agreement with The Mad Hatter Coffee
& Tea Co., will initially allow us to distribute our tea in the
US, following with global distribution. This first product launch
enables Endexx to generate licensing agreements with several large
family owned conglomerates and distributors that have expressed
strong interest in licensing our products, providing for additional
revenue opportunities."
About Endexx
Endexx provides innovative inventory management and technology
solutions. Endexx, with its collaborative partners and consultants,
develops and distributes two consumable product lines derived from
industrial hemp, which is organic and naturally rich in
phytocannabinoids. Phyto-Bites®, is its CBD-infused soft chews for
dogs. The dog treats are formulated to promote health and support
the reduction of separation anxiety, pain and inflammation. The
company also has two technology products and services that launched
in 2014 -- the M3hub and the Autospense™. Both products provide
essential solutions to promote regulatory compliance and full
accountability through "seed to sale" inventory management and an
"End of Sale" technology integration. Based on principles developed
by the pharmacological industry, the m3hub platform is the first
standardized software solution for tracking pharmaceutical grade
marijuana that maintains compliance with federal, state and local
regulations. It is intended to provide a smooth transition to
eventual federal mandates. The Autospense™ is a commercial grade
inventory control and dispensing device that provides
up-to-the-minute accounting details and ensures both product and
patient security. By automating the dispensing process, Autospense™
increases productivity and reduces costs for marijuana retailers,
while enhancing their service quality by reducing transaction time
for customers. Websites include: www.cbdunlimited.com, www.endexx.com, www.m3hub.com.
Safe Harbor Notice
This press release may contain "forward-looking statements" within
the meaning of the Private Securities Litigation Reform Act of
1995, such as statements relating to financial results and plans
for future development activities, and are thus prospective.
Forward-looking statements include all statements that are not
statements of historical fact regarding intent, belief or current
expectations of the Company, its directors or its officers.
Investors are cautioned that any such forward-looking statements
are not guarantees of future performance and involve risks and
uncertainties, many of which are beyond the Company's ability to
control. Actual results may differ materially from those projected
in the forward-looking statements. Among the factors that could
cause actual results to differ materially from those indicated in
the forward-looking statements are risks and uncertainties
associated with the Company's business and finances in general,
including the ability to continue and manage its growth,
competition, global economic conditions and other factors discussed
in detail in the Company's periodic filings with the Security and
Exchange Commission. The Company undertakes no obligation to update
any forward-looking statements.